GAITHERSBURG, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical ...

Pasithea Therapeutics Announces Initiation of Phase 1/1B Study of PAS-004 in Adult NF1 Patients and Activation of First ...

(Reuters) - Alphabet's self-driving unit, Waymo, is recalling 1,212 vehicles after some cars collided with roadway barriers ...

Nvidia and AMD extend gains after the chip makers sign deals with Saudi Arabia, UnitedHealth claws back some losses from the ...

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint ...

Rackham "But I must explain to you how all this mistaken idea of denouncing pleasure and praising pain was born and I will ...

Shares of Nvidia (NASDAQ:NVDA) jumped more than 6% Tuesday after the chipmaker struck a deal with Saudi Arabia's AI firm ...

Highlights,Institutional changes in Viavi Solutions included both reductions and increases in holdings.,Tower Research ...

Discover how Sweetgreen (NYSE:SG) is navigating institutional activity and revenue trends while enhancing its brand reach. As ...

Explore how Klaviyo (NYSE:KVYO) is gaining momentum through institutional interest and cloud-native services. With global ...

Explore Omeros Corporation (NASDAQ:OMER), a biopharmaceutical company advancing clinical programs and gaining institutional ...

Explore how Wabash National (NYSE:WNC) is responding to revenue changes and institutional reshuffling. With a focus on ...